Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SURMODICS INC Director's Dealing 2017

Nov 30, 2017

32845_dirs_2017-11-30_68d9c919-7b9f-4dde-864c-477d358374f3.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SURMODICS INC (SRDX)
CIK: 0000924717
Period of Report: 2017-11-28

Reporting Person: OLSON CHARLES W (Senior VP of Bus Dev, Med Dev)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-11-28 Common Stock A 3915 $0.00 Acquired 35362 Direct
2017-11-28 Common Stock A 6525 $0.00 Acquired 41887 Direct
2017-11-28 Common Stock F 3146 $33.20 Disposed 38741 Direct
2017-11-30 Common Stock F 436 $33.10 Disposed 38305 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2017-11-28 Employee Stock Option (right to buy) $33.20 A 18447 Acquired 2024-11-28 Common Stock (18447) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 800 Indirect

Footnotes

F1: Shares issued in connection with the vesting of a performance share award under long-term incentive plan based on performance during three-year period ended September 30, 2017.

F2: Shares withheld to satisfy taxes incident to vesting of performance share award.

F3: The award vests in four equal installments on each of the first four anniversaries of the November 28, 2017 grant date.